Invex Therapeutics Ltd (ASX:IXC)
Australia · Delayed Price · Currency is AUD 0.1150
0.00 (0.00%)
Sep 16, 2026, 12:33 PM AEST
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 8.64 million as of September 17, 2026. Its market cap has increased by 15.00% in one year.
Market Cap
8.64M
Enterprise Value
4.63M
Revenue
46.83K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
ChartMarket Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 8.64M, a decrease of -85.38%. That is a compound annual growth rate of -23.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 8.64M | -4.17% |
| Dec 30, 2025 | 9.02M | 81.82% |
| Dec 23, 2024 | 4.96M | -18.52% |
| Dec 27, 2023 | 6.09M | -85.14% |
| Dec 28, 2022 | 40.96M | -22.70% |
| Dec 31, 2021 | 52.98M | -1.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immuron | 14.21M |
| Ceryvyn Therapeutics | 13.68M |
| Cambium Bio | 13.54M |
| ReNerve | 12.23M |
| AdAlta | 9.64M |
| Bio-Gene Technology | 7.45M |
| Vectus Biosystems | 7.40M |
| Zelira Therapeutics | 5.95M |